| 摘要 |
FIELD: medicine. ^ SUBSTANCE: there described are antibodies to P-selectin and namely antibodies to P-selectin and their versions which include Fc-portion of human origin and do not bind Clq complement factor. There specified is pharmaceutical composition containing the above antibody. ^ EFFECT: possibility of being used for treatment of the patient suffering critical ischemia of limbs or occlusive disease of peripheral arteries(CIL/ODPA). ^ 4 cl, 10 dwg, 6 tbl |
